Cancer, Evolution, ALife: Discovery of Cancer Treatment
Aim and scope
The International Workshop on Cancer, Evolution, ALife is a meeting organized by the EVO-NANO consortium, where scientists from many different backgrounds are united in their interest in interdisciplinary approaches towards origins and development of cancers, innovative ways of searching for cancer treatment such as nanomedicine, and the role of cancer in evolution of the species.
Topics of Interest
Papers and presentations are sought in all areas that relate to search for cancer treatment using AI and evolutionary optimisation, automatic optimisation of treatments such as nanomedicine and immunotherapy, novel modelling techniques, molecular origin of cancer, the role of cancer in evolution of species, interpretation of cancer in terms of artificial life and artificial immune systems, swarm intelligence, cellular automata, computational systems biology, genetic networks, cellular computing, validation through in vitro/vivo tumour models and tumour-on-a-chip devices. Both theoretical and experimental papers are welcome.
Extended versions of selected papers from the workshop will appear in a special issue of the Journal of Parallel, Emergent and Distributed Systems and/or BioSystems.
Workshop date: May 27, 2020
How to join
https://aboakademi.zoom.us/j/63405916022
ZOOM Meeting ID: 634 0591 6022
Passcode: 252520
Central European Time (CET) | |
Workshop Opening (resolving technical issues, welcoming statement, very short introduction of attendes) | 9:00 |
Invited talk: Is cancer a form of cellular organised crime? Dan V. Nicolau Queensland University of Technology, Australia and University of Oxford, UK | 9:10 |
Invited talk: Targeting cancer cells by altering pre-mRNA splicing Michael R. Ladomery Faculty of Health and Applied Sciences, UWE, Bristol, UK | 9:40 |
Evolutionary computation in the service of the fight against cancer Michail-Antisthenis Tsompanas, Larry Bull, Andrew Adamatzky and Igor Balaz University of the West of England, UK and University of Novi Sad, Serbia | 10:30 |
Coffee Break (please bring your own) | 11:00 |
Adaptive Novelty and Automated Generation of Cancer Treatments in Simple Agent-based Model Igor Balaz, Tara Petric, Marina Kovacevic, Namid Stillman, Antisthenis Tsompanas University of Novi Sad, Serbia, University of Bristol and University of the West of England, UK | 11:30 |
Vessel-on-chip in-vitro model for nanomedicine validation Jean Cacheux, Sergio Davila and Isabel Rodriguez IMDEA Nanoscience C/ Faraday, Spain | 12:00 |
Therapeutic Manipulation of Macrophages for the Treatment of Cancer using Nanoparticles Fernando Torres Andón, Maria Jose Alonso, Paola Allavena Universidadae De Santiago De Compostela | 12:30 |
Systems-based biomarkers for precision oncology Federica Eduati Eindhoven University of Technology, Netherlands | 13:00 |
Lunch Break (please bring your own) | 13:30 |
Explainable AI for Nanoparticle Design in Cancer Treatment Sepinoud Azimi, Marina Kovacevic, Sebastien Lafond, Igor Balaz Åbo Akademi University, Finland and University of Novi Sad, Serbia | 14:00 |
Determination of the physiological effect of functionalized nanoparticles (CSC dynamic models) Petra Gener Vall d’Hebron Institut de Recerca, Spain | 14:30 |
Convenient and versatile platform based on functionalized gold nanoparticles for assessment of biological activity Dariusz Witt ProChimia Surfaces, Poland | 15:00 |
Overcoming Nanoparticle Transport Barriers using in silico/in vitro Methods Namid Stillman, Scott McCormick, Sabine Hauert University of Bristol, UK | 15:30 |
The Dynamic Optical Micro-Environment (DOME) Ana Maria Rubio Denniss, Thomas Gorochowski, Sabine Hauert University of Bristol, UK | 16:00 |
Invited Talk: Universal Criticality Beyond Edge Of Chaos, Derived From Proto-Anticipation Gunji Yukio-Pegio Waseda University, Japan | 16:30 |